Cargando…

Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy

Adenoviral vectors (AdVs) have attracted much attention in the fields of vaccine development and treatment for diseases such as genetic disorders and cancer. In this review, we discuss the utility of AdVs in cancer therapies. In recent years, AdVs were modified as oncolytic AdVs (OAs) that possess t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jian, Zhang, Wenli, Ehrhardt, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281331/ https://www.ncbi.nlm.nih.gov/pubmed/32370135 http://dx.doi.org/10.3390/cancers12051139

Ejemplares similares

High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
por: Ricobaraza, Ana, et al.
Publicado: (2020)

Enhanced Tropism of Species B1 Adenoviral-Based Vectors for Primary Human Airway Epithelial Cells
por: Li, Ni, et al.
Publicado: (2019)

A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration
por: Boehme, Philip, et al.
Publicado: (2016)

Rescue of chimeric adenoviral vectors to expand the serotype repertoire
por: Roy, Soumitra, et al.
Publicado: (2007)

Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Improving adenoviral vectors and strategies for prostate cancer gene therapy
por: Tamura, Rodrigo Esaki, et al.
Publicado: (2018)

A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications
por: Voigtlander, Richard, et al.
Publicado: (2013)

Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
por: Tessarollo, Nayara Gusmão, et al.
Publicado: (2021)

Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)

Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells
por: Ehrke-Schulz, Eric, et al.
Publicado: (2020)

A Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions
por: Tsoukas, Raphael L., et al.
Publicado: (2022)

CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes
por: Ehrke-Schulz, Eric, et al.
Publicado: (2017)

The Role of Chromatin in Adenoviral Vector Function
por: Wong, Carmen M., et al.
Publicado: (2013)

Spectrum-Wide Exploration of Human Adenoviruses for Breast Cancer Therapy
por: Mach, Nicolas, et al.
Publicado: (2020)

Adenoviral vector-based strategies against infectious disease and cancer
por: Zhang, Chao, et al.
Publicado: (2016)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine
por: Sallard, Erwan, et al.
Publicado: (2023)

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy
por: Piccolo, Pasquale, et al.
Publicado: (2014)

One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
por: Schiwon, Maren, et al.
Publicado: (2018)

Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
por: Farzad, Lisa M., et al.
Publicado: (2014)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
por: Vetrini, Francesco, et al.
Publicado: (2010)

Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective
por: JT, Schwartze, et al.
Publicado: (2022)

The use of adenoviral vectors in gene therapy and vaccine approaches
por: Araújo, Natália Meneses, et al.
Publicado: (2022)

Human adenoviral (HAdV) chronic arthritis expands the infectious spectrum of primary agammaglobulinemia
por: de Frémont, Grégoire Martin, et al.
Publicado: (2022)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022)

Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
por: Dobner, Thomas, et al.
Publicado: (2023)

Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents
por: Del Papa, Joshua, et al.
Publicado: (2017)

Use of adenoviral vectors as veterinary vaccines
por: Ferreira, T B, et al.
Publicado: (2005)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications
por: Capasso, Cristian, et al.
Publicado: (2014)

Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
por: Kreppel, Florian, et al.
Publicado: (2021)

Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
por: Tazawa, Hiroshi, et al.
Publicado: (2017)

Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy
por: Bandara, Ranmal Avinash, et al.
Publicado: (2021)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_78u96mabohopalbenu9lrslike